| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | -0.18 | 3e-05 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.16 | 3e-05 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.16 | 3e-05 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.16 | 4e-05 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.14 | 8e-05 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.15 | 0.0001 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.23 | 0.0001 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | -0.17 | 0.0002 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0002 |